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Background: Several lines of evidence indicate mitochondrial impairment in the pathophysiology of autism. As
one of the most common biomarkers for mitochondrial dysfunction, mitochondrial DNA (mtDNA) copy number has
also been linked to autism, but the relationship between mtDNA copy number and autism was still obscured. In
this study, we performed a case–control study to investigate whether mtDNA copy number in peripheral blood
cells is related to patients with autism.
Methods: Relative mtDNA copy number in peripheral blood cells was measured by using real-time polymerase
chain reaction method. The participants in this study included 78 patients with childhood autism and 83 typically
developing children.
Results: We observed children with autism had significantly elevated relative mtDNA copy number than healthy
controls (Beta = −0.173, P = 0.0003). However, there were no significant correlations between mtDNA copy number
and clinical features (paternal age, maternal age, age of onset, illness of duration, CARS score and ABC score) in
childhood autism.
Conclusion: We show that elevated mtDNA copy number in peripheral blood is associated with autism, indicating
that there may be mitochondrial dysfunction in children with autism.
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Autism is a neurodevelopmental disorder, characterized
by social deficits, communication impairment and un-
usually restricted, repetitive behaviors with onset prior to
three years of age. The worldwide prevalence of autism
spectrum disorder (ASD) is estimated at about 0.7%, al-
though the estimates vary with populations [1,2]. Because
of the complex, multifactorial etiology and pathophysi-
ology underlying this illness and the limited scientific* Correspondence: chenxghn@gmail.com; tangjinsonghn@gmail.com
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unless otherwise stated.advance, the pathogenesis of autism is still elusive. It is
consensually believed that gene–environment interplay
contributes to the development of autism [3,4]. Increasing
evidence has shown that mitochondrial dysfunction is as-
sociated with autism and there is much higher prevalence
of mitochondrial diseases in autism than that in general
population of children [5-7].
Mitochondria are specialized cellular organelle generat-
ing adenosine triphosphate (ATP) through oxidative phos-
phorylation that is a series of chemical reactions in the
electron transport chain (ETC). In addition, mitochondria
play important roles in other biological activities of cells,
such as apoptosis and calcium regulation, and are the
major intracellular source and primary target of reactive
oxygen species (ROS) that is toxic for mitochondria [8,9].
In normal cells, each mitochondrion carries about 2 to 10
copies of mitochondrial DNA (mtDNA). The mtDNA is ahis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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genes, which codes partial proteins of ECT enzyme com-
plexes and partial components of the machinery of intra-
mitochondrial protein synthesis. Comparing with nuclear
DNA, mtDNA is lack of protective histones and has lim-
ited DNA repair capacity, and therefore is highly suscep-
tible to intramitochondrial ROS [10].
Increased oxidative stress has been found in patients with
autism [11-13]. This leads to high rates of mutation and de-
letion for mtDNA, and subsequently impairs the mitochon-
drial function [14]. Evidence of different lines supports a
role of mitochondrial impairment in the pathophysiology of
autism [5,15-21]. Studies of peripheral blood and lympho-
blastoid cell lines have identified ETC complexes deficiency
and disordered mitochondrial energy metabolism such as
plasma lactate, pyruvate, carnitine and amino acids in indi-
viduals with autism [19]. Similarly, previous magnetic reson-
ance spectroscopy study has showed increased lactate
doublets, decreased synthesis of ATP and a disturbed energy
metabolism in the brain of autism [21]. Postmortem human
brain studies in autism have also found decreased protein
expressions of ETC complexes in specific region of brain,
reinforcing the mitochondrial dysfunction in this illness
[20]. Abnormal mtDNA number, as one of the most com-
mon biomarkers, has been observed associated with mito-
chondrial dysfunction and increased oxidative stress [22-25].
Previous studies have suggested that mtDNA copy num-
ber may increase with mtDNA damage or mitochondrial
dysfunction, and compensate for the mitochondrial energy
metabolism in patients with ASD [20]. Other studies failed
to find this abnormality in ASD [19,26]. Considering the
ASD defined by a constellation of different classes of sub-
types, the diversity of ASD and the limited sample size in
these studies may account for the inconsistent results. In
an attempt to elucidate this association, we performed a
large case–control study to investigate the status of per-




The study included 78 children with autism and 83 typically
developing children. All subjects age from 3 to 6 years and
were Han Chinese ethnicity. Children with autism were
consecutively recruited from the department of Children
psychology, MCH Hospital of Shenzhen and Institute of
Mental Health, Second Xiangya Hospital of Central South
University from July 2011 to December 2012. All patients
were diagnosed by two senior psychiatrists according to
DSM-IV diagnostic criteria-based structured interview for
autism. In addition, all cases were also assessed by using
childhood autism rating scale (CARS) and autism behavior
checklist (ABC) [27,28]. Exclusion criteria for children in-
cluded: autistic patients with age above 6 years, patientswith Rett syndrome, childhood schizophrenia, Asperger’s
syndrome or pervasive developmental disorder-not other-
wise specified (PDD-NOS).
All typically developing children were recruited from
community volunteers. The current mental status and
history of mental disorders of the control subjects were
evaluated by a senior psychiatrist. Controls recruited
when individuals met the criteria and did not have any
history of mental disorders, neurological disorders, sub-
stance abuse and serious physical diseases. Unfortunately
we failed to obtain a family history of mental disorders.
Written informed consents conforming to the princi-
ples expressed in the Declaration of Helsinki were ob-
tained from the guardians of all participants. The study
was approved by the Human Ethics Committee of the
Second Xiangya Hospital.
Clinical assessment
The severity of autism was assessed by CARS, which
rates the child on a scale from one to four in each of 15-
items behavioral rating scale. The items are: relating to
people; emotional response; imitation; body use; object
use; listening response; fear or nervousness; verbal com-
munication; non-verbal communication; activity level;
level and consistency of intellectual response; adaptation
to change; visual response; taste, smell and touch re-
sponse and general impressions. Children with a total
score above 30 were considered autistic and were in-
cluded in this study [27].
The ABC consists in 57 items about the atypical behav-
iors and these behaviors are related to five areas (sensory
stimuli sensorial; relating; body and object use; language so-
cial; self-help). Most items scored from 1 to 4 according to
the impairment degree. Children with scores above 53 were
considered autism and were included in this study [28].
Laboratory analysis
Peripheral blood samples were collected in EDTA tubes
and kept at −20°C before use. Genomic DNA was isolated
from 200 ul of each blood sample using a commercial DNA
Isolation Kit NEP004-1 (Beijing Dingguo Changsheng Bio-
technology Co., Ltd., China). The procedure for DNA
extraction and purification was performed by using the
silica-membrane-based spin column method. The quantity
and purity of the DNA was assayed using a Nanodrop 2000
spectrophotometer (Thermo Scientific, Wilmington, DE,
USA) and all DNA samples all had OD260/OD280 values
of 1.7–2.0. Then total DNA samples were stored at −70°C
until use.
The relative mtDNA copy number was measured by
quantitative real-time polymerase chain reaction (PCR) and
normalized by simultaneous measurement of the nuclear
DNA according the method described in previous studies
[29-31]. In brief, the primer sequences L394, 5′-
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ATT-GATGAGATTAGT-3′ were used for measuring the
mtDNA content, and primers HBG1F, 5′-GCTTCTGACA
CAACTGTGTTCACTAGC-3′/HBG1R 5′-CACCAACTT
CATCCACGTTCACC-3′ were used for amplification the
single-copy nuclear ß-globin gene [29]. Assay was per-
formed by using the Maxima SYBR Green qPCR Master
Mix (Thermo Fisher Scientific, Waltham, MA, USA) sup-
plied by CFX96 Real-Time Detection Systems (BioRad La-
boratories, Hercules, CA, USA). The qPCR was performed
under the following conditions: denaturation at 95°C for
10 minutes followed by 40 cycles of 10s at 95°C, 30 at 60°C
and 30s at 72°C. All assays were carried out in triplicate
using 10 ng DNA per 10 μl reaction. The acceptable stand-
ard deviation (SD) of the triplicate threshold cycle (Ct)
values was set at 0.3. If the result was out of the acceptable
range, then the run was repeated for the same sample. The
relative mtDNA copy number was calculated by the equa-
tion 2−ΔΔCt (ΔCt =CtmtDNA-Ctβ-globin) [32,33].
Statistical analysis
All statistical analyses were performed with the Statistical
Package for the Social Sciences (SPSS, version 20.0 for
Windows). The difference in the distribution of character-
istics between the cases and the controls was evaluated by
chi-square test for categorical variables (gender) and Stu-
dent’s t-test for continuous variables (age). Age and sex of
the participants, as well as the batch used for mtDNA
copy number measurement, were included as covariates
in linear regression in order to rule out confounding ef-
fects. For comparisons between multiple groups, one-way
ANOVA followed by LSD test for multiple comparisons
between any of the two groups was carried out. Mono-
tonic relationships between mtDNA copy number and
clinic parameters of autism were examined by using linear
regression analysis. All P-values were two-sided and con-
sidered statistically significant at <0.05.Table 1 Demographic and clinical characteristics of autism pa
Variables Cases (n = 78)




Family training (yes/no)* 27/35
Paternal age, years (mean±SD)* 30.18±4.64
Maternal age, years (mean±SD)* 27.34±4.68
Age of onset, years (mean±SD)* 2.05±0.71
Illness of duration, years (mean±SD)* 2.49±1.20
CARS Score, (mean±SD)* 34.48±3.01
ABC Score, (mean±SD)* 105.44±9.55
*Data from 16 of 78 cases (same subjects) were missing.Results
A total 78 patients with autism and 83 healthy controls
were included in this study. The mean age of autism pa-
tients and healthy controls were 45.4 ± 12.3 and 47.3 ±
12.5 months, respectively (p = 0.413, Table 1). There was no
sex difference between autism cases and healthy control
samples (p = 0.175), although there were more female con-
trols (n = 16) than cases (n = 9). In addition, the mean
CARS and ABC scores in cases were 34.48 ± 3.01 and
105.44 ± 9.55, respectively. The relative mtDNA copy num-
ber was skewed distributed in both autism cases and
healthy control. The mean of relative mtDNA copy num-
bers was 9.16 (SD = 11.6) in cases and 3.052 (SD = 4.252) in
controls; both were far from its medians, 1.624 for autism
cases and 1.257 for controls (Table 2). There was a quite
large standard deviation in both groups. We performed
eighth root transformation, which made the means and me-
dian of transformed mtDNA very close in both autism
cases (1.135 ± 0.293 vs 1.062) and controls (0.960 ±0.288 vs
1.029), suggesting the transformed mtDNA are symmetric
distribution, and variations were close in two groups.
Linear regression analysis of both mtDNA and trans-
formed mtDNA while controlling for age and sex
showed an elevated mtDNA copy number in autism
cases (Table 3). In the transformed mtDNA, mtDNA
copy number is lower in controls compared to the aut-
ism cases (beta=−0.173, p=0.0003; Figure 1). Age and
sex were not associated with mtDNA and transformed
mtDNA. Stratification analysis by sex also showed the
similar trend in males (beta=−0.172, p=0.0008). How-
ever, we did not observe significant association of
mtDNA copy number with the disease in females (beta=
−0.214, p=0.1056), although the effect size is slight lar-
ger. This may because the sample size is relative small
and lack adequate statistical power to detect this associ-
ation in females. We did not observe any significant
interaction between the disease status and sex, and age.tients and healthycontrols





Table 2 Summary statistics of relative mtDNA in autism cases and controls and by sexin autism cases and controls
Status N Variable Mean Median SD Min Max 25th Pctl 75th Pctl
Overall
Control 83 mtDNA 3.052 1.257 4.252 0.004 23.702 0.041 5.153
sqrtmtDNA 0.960 1.029 0.288 0.495 1.485 0.671 1.227
Autism 78 mtDNA 9.165 1.624 11.596 0.015 35.585 0.807 19.004
sqrtmtDNA 1.135 1.062 0.293 0.590 1.563 0.974 1.445
Male
Control 67 mtDNA 3.056 0.979 4.454 0.004 23.702 0.045 4.885
sqrtmtDNA 0.955 0.997 0.289 0.495 1.485 0.679 1.219
Autism 69 mtDNA 8.994 1.617 11.369 0.015 35.585 0.762 18.724
sqrtmtDNA 1.131 1.062 0.295 0.590 1.563 0.967 1.442
Female
Control 16 mtDNA 3.037 1.585 3.399 0.014 8.473 0.036 6.681
sqrtmtDNA 0.979 1.057 0.291 0.589 1.306 0.660 1.267
Autism 9 mtDNA 10.478 2.570 13.908 0.038 32.939 1.030 20.978
sqrtmtDNA 1.167 1.125 0.298 0.665 1.548 1.004 1.463
Note: sqrtmtDNA—Eighth-root transformation of mtDNA.
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ber and clinical features in autism cases are shown in
Table 4. No significant associations were observed be-
tween relative mtDNA copy number and clinical features
(paternal age, maternal age, age of onset, illness of dur-
ation, CARS score and ABC score) in patients with
childhood autism. Similarly, there was no difference of
relative mtDNA copy number between patients with and
without family training interaction (Figure 2).Table 3 Linear regression analysis of mtDNA and eighth-
root transformed mtDNA and by sex in autism cases and
controls
mtDNA Eighth-root transformed
Parameter Beta SE P Beta SE P
Overall
Intercept 12.296 3.050 <.0001 1.248 0.103 <.0001
Control vs autism −6.037 1.375 <.0001 −0.173 0.046 0.0003
Female vs Male −0.317 1.904 0.8679 −0.0207 0.064 0.7469
Age −0.062 0.056 0.2636 −0.0021 0.0019 0.2715
Male
Intercept 11.976 2.906 <.0001 1.259 0.097 <.0001
Control vs autism −5.849 1.490 0.0001 −0.172 0.050 0.0008
Age −0.064 0.058 0.2735 −0.0028 0.0019 0.16
Female
Intercept 11.763 8.332 0.172 0.9504 0.2782 0.0025
Control vs autism −7.284 3.803 0.0685 −0.2144 0.1270 0.1056
Age −0.032 0.193 0.8705 0.00535 0.0064 0.4143Discussion
In this study, we measured the relative mitochondrial
DNA copy number in peripheral blood cells using quan-
titative PCR technique in autism patients and healthy
controls. Our study found significant difference in the
relative mtDNA copy number between childhood autism
and healthy controls, and an elevated mtDNA content
level was observed in patients with autism.
Unlike the findings reported in previous studies that
the mtDNA copy number was negatively correlative with
age in healthy populations [34-36], this study showed no
association between mtDNA copy number and age in
case and control groups. This may due to the narrow
age span of subjects included in our study (3–6 years),
and lack of adequate statistical power to detect this asso-
ciation. In addition, no significant associations wereFigure 1 Relative mtDNAcopy number of autistic patients and
health controls.
Table 4 Correlations between mtDNA copy number and
clinical variables in childhood autism
Variables Beta P value
Paternal age 0.009 0.297
Maternal age 0.002 0.778
Age of onset −0.032 0.562
Illness of duration −0.030 0.361
CARS Score −0.002 0.873
ABC Score −0.001 0.844
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nal age, maternal age, age of onset, illness of duration, CARS
score, ABC score, and family training status in childhood
autism. This indicates that the mtDNA copy number has no
direct impact on clinical features of autism.
Our finding is consistent with previous brain tissue-based
study that showed an aberrant elevated mtDNA copy num-
ber in autism patients [20]. Gu et al. analyzed mtDNA copy
number with the brain tissues in 9 autistic children and 9
controls, and they found increased copy numbers of three
mitochondrial genes (ND1, ND4, CYTB) in autistic pa-
tients, which indicated higher mtDNA copy numbers in
autism. However, this finding was failed to be replicated by
a following postmortem study [26]. Tang et al. examined
the of brain mtDNA in childhood subjects, including 8
ASD children and 7 controls and found that no mtDNA
copy number are associated with ASD patients [26]. Simi-
larly, Giulivi et al. evaluated mtDNA copy number in per-
ipheral lymphocytes from 10 children with autism and 10Figure 2 MtDNA copy number in autism with and without family
training compared with controls. One-way analysis of variance (ANOVA)
of the mean values was used to analyze the difference of mtDNA copy
number among groups (F=6.042, P = 0.003) and the LSD test was used
for multiple comparisons between any of the two groups. The differences
of mtDNA copy number betweencontrol group and autism subgroup
without family training, and autism subgroup withfamily trainingwere
statistically significant (P = 0.002, 0.024, respectively). There is no significant
difference in mtDNA copy number between patients with and without
family training(p=0.592).controls. They found that the mean mtDNA copy number
in lymphocytes was not significantly different in overall
association. However, 5 of 10 children with autism pre-
sented mtDNA over-replication compared with 95% CI of
the value in control children [19]. A small sample size and
the different tissues cells may account for this inconsist-
ency in previous studies. We measured mtDNA content
in peripheral lymphocytes from 161 subjects and found
autistic children had higher copy numbers of mtDNA
when compared with healthy children group. The in-
creased mtDNA copy number may be caused by compen-
satory mtDNA over-replication or a disruption of mtDNA
degradation, which indicated a dysfunctional state in mito-
chondria. Therefore, these findings showed mitochondrial
dysfunction in children with autism and proved a previous
finding that mitochondrial dysfunction may be a biological
subtype of autism spectrum disorder [21].
The major strength of our study is the unique and
highly homogenous patient subjects. ASD is a heteroge-
neous group of common developmental disorders includ-
ing autism, Rett syndrome, Asperger’s syndrome and
PDD-NOS. Our study is just restricted to childhood aut-
ism, excluding the patients with atypical autism and adult
autism. Thus, any potential confounding effects yielded by
different sub-diseases aetiology were eliminated, which
may be efficient in this association study to evaluate the
mtDNA status in childhood autism. Furthermore, we ana-
lyzed 161 children subjects in this study, which is much
larger than the sample size in previous studies.
We have to note that there are several limitations in the
present study. First, because the inherent limitation of case–
control design, the finding may not be used to make causal
inference on the association of elevated mtDNA copy num-
ber with the risk of autism; and potential population stratifi-
cation was not controlled. In addition, while we analyzed
mtDNA copy number in peripheral blood cells, brain tissues
are considered as the standard target tissue for studying aut-
ism or other brain disorders. However, peripheral blood cells
can be obtained in noninvasive method; and the mtDNA
copy number in peripheral blood has been associated with
that in brain tissues [37,38]. The mtDNA copy number in
peripheral blood might serve as an alternative indicator for
the mitochondrial function in brain tissues. Furthermore,
the incomplete data on characteristics of autism and con-
trols did not allow controlling more potential confounding.
Conclusion
In this study we observed the mtDNA copy number in per-
ipheral blood is significantly elevated in children with aut-
ism. Our finding supports the previous statement that there
is mitochondrial dysfunction in patients with autism and
indicates mitochondrial dysfunction may be a biological
subtype of childhood autism. Additional research is needed
to assess whether the association is replicable in the future.
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